Total Payments
$16,526
2024 Payments
$7,167
Companies
12
Transactions
36
Medicare Patients
3,857
Medicare Billing
$322,871
Payment Breakdown by Category
Research$7,083 (42.9%)
Consulting$6,345 (38.4%)
Food & Beverage$1,719 (10.4%)
Travel$1,380 (8.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,083 | 8 | 42.9% |
| Consulting Fee | $6,345 | 1 | 38.4% |
| Food and Beverage | $1,719 | 23 | 10.4% |
| Travel and Lodging | $1,380 | 4 | 8.4% |
Payments by Type
General
$9,444
28 transactions
Research
$7,083
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $7,083 | 8 | $0 (2024) |
| Genentech, Inc. | $7,082 | 5 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $806.34 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $366.74 | 3 | $0 (2019) |
| Carl Zeiss Meditec USA, Inc. | $273.51 | 2 | $0 (2022) |
| Allergan, Inc. | $249.91 | 3 | $0 (2020) |
| Dutch Ophthalmic, USA | $217.63 | 3 | $0 (2023) |
| Alcon Laboratories Inc | $173.57 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $148.55 | 2 | $0 (2019) |
| Genentech USA, Inc. | $78.60 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,167 | 12 | F. Hoffmann-La Roche AG ($7,083) |
| 2023 | $7,115 | 5 | Genentech, Inc. ($6,919) |
| 2022 | $280.89 | 3 | Genentech, Inc. ($133.11) |
| 2021 | $184.37 | 3 | Carl Zeiss Meditec USA, Inc. ($153.26) |
| 2020 | $125.00 | 1 | Allergan, Inc. ($125.00) |
| 2019 | $1,173 | 5 | Regeneron Pharmaceuticals, Inc. ($806.34) |
| 2018 | $481.42 | 7 | Alcon Laboratories Inc ($173.57) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $835.00 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 09/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $752.00 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 08/07/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $2,130.00 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 06/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $1,041.11 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 06/30/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $436.36 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 05/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/31/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $753.57 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 03/31/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $601.25 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 03/31/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $533.33 | Research |
| Study: VA2 PhIII Yosemite | ||||||
| 01/25/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/06/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $171.51 | General |
| Category: Ophthalmology | ||||||
| 07/14/2023 | Genentech, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $6,345.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/14/2023 | Genentech, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $326.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/14/2023 | Genentech, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $246.93 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/29/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/02/2022 | Carl Zeiss Meditec USA, Inc. | ARTEVO 800 (Device) | Food and Beverage | In-kind items and services | $120.25 | General |
| Category: Digital Microscope | ||||||
| 09/19/2022 | Dutch Ophthalmic, USA | EVA, combined machine (Device) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Ophthalmology | ||||||
| 05/03/2022 | Genentech, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $133.11 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/22/2021 | Akorn Operating Company LLC | Zioptan (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Opthalmic glaucoma agent | ||||||
| 06/07/2021 | Carl Zeiss Meditec USA, Inc. | ARTEVO 800 (Device) | Food and Beverage | In-kind items and services | $153.26 | General |
| Category: Digital Microscope | ||||||
| 05/05/2021 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Ophthalmology | ||||||
| 02/06/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RETINA | ||||||
| 08/14/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $119.85 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| VA2 PhIII Yosemite | F. Hoffmann-La Roche AG | $7,083 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,146 | 2,217 | $818,666 | $96,655 |
| 2022 | 10 | 1,199 | 2,084 | $847,071 | $102,956 |
| 2021 | 11 | 1,203 | 2,173 | $769,354 | $98,348 |
| 2020 | 7 | 309 | 379 | $209,340 | $24,912 |
Total Patients
3,857
Total Services
6,853
Medicare Billing
$322,871
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Facility | 2023 | 118 | 312 | $247,085 | $24,688 | 10.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 67 | 273 | $198,900 | $19,964 | 10.0% |
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 181 | 261 | $105,183 | $14,399 | 13.7% |
| 92134 | Imaging of retina | Facility | 2023 | 295 | 576 | $81,796 | $10,690 | 13.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 131 | 174 | $70,122 | $9,546 | 13.6% |
| 92134 | Imaging of retina | Office | 2023 | 195 | 455 | $66,885 | $8,275 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 32 | $12,018 | $2,459 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $10,600 | $1,745 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,950 | $1,540 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 27 | 28 | $3,719 | $1,421 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $5,432 | $691.66 | 12.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Facility | 2023 | 15 | 19 | $4,455 | $653.07 | 14.7% |
| 92250 | Photography of the retina | Facility | 2023 | 36 | 38 | $4,522 | $582.08 | 12.9% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 254 | 349 | $140,446 | $20,413 | 14.5% |
| 67028 | Injection of drug into eye | Facility | 2022 | 107 | 268 | $205,516 | $20,210 | 9.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 53 | 209 | $147,849 | $15,118 | 10.2% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 13 | 13 | $100,191 | $11,963 | 11.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 138 | 182 | $73,346 | $10,235 | 14.0% |
| 92134 | Imaging of retina | Facility | 2022 | 327 | 550 | $78,758 | $10,155 | 12.9% |
| 92134 | Imaging of retina | Office | 2022 | 159 | 363 | $53,361 | $6,822 | 12.8% |
| 92004 | New patient complete exam of visual system | Facility | 2022 | 35 | 35 | $17,500 | $2,654 | 15.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $6,942 | $1,536 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 14 | $4,237 | $1,036 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 30 | 30 | $5,055 | $997.12 | 19.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Facility | 2022 | 25 | 25 | $5,871 | $791.36 | 13.5% |
About Dr. Niranjan Manoharan, MD
Dr. Niranjan Manoharan, MD is a Ophthalmology healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1598182453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niranjan Manoharan, MD has received a total of $16,526 in payments from pharmaceutical and medical device companies, with $7,167 received in 2024. These payments were reported across 36 transactions from 12 companies. The most common payment nature is "" ($7,083).
As a Medicare-enrolled provider, Manoharan has provided services to 3,857 Medicare beneficiaries, totaling 6,853 services with total Medicare billing of $322,871. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Aurora, CO
- Active Since 03/27/2014
- Last Updated 08/31/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1598182453
Products in Payments
- Vabysmo (Drug) $6,995
- ARTEVO 800 (Device) $273.51
- OZURDEX (Drug) $249.91
- EVA, combined machine (Device) $199.04
- AcrySof (Device) $150.00
- VABYSMO (Drug) $133.11
- EYLEA (Biological) $125.00
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $34.40
- Susvimo (Drug) $32.30
- CyPass (Device) $23.57
- EYLEA AFLIBERCEPT INJECTION (Biological) $23.55
- EVA Ophthalmic Surgical System (Device) $18.59
- Zioptan (Drug) $12.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Aurora
Malik Kahook, Md, MD
Ophthalmology — Payments: $2.8M
Ophthalmology $2.8M
Richard Davidson, Md, MD
Ophthalmology — Payments: $271,536
Ophthalmology $271,536
Dr. Cecelia Koetting, O.d, O.D
Ophthalmology — Payments: $267,905
Ophthalmology $267,905
Leonard Seibold, Md, MD
Ophthalmology — Payments: $50,699
Ophthalmology $50,699
Michael Taravella, Md, MD
Ophthalmology — Payments: $13,888
Ophthalmology $13,888
Dr. Lynn Hassman, Md, MD
Ophthalmology — Payments: $9,122
Ophthalmology $9,122